Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lead Real Estate ADR | LRE | Nov 21, 2024 | 2.17 | +1.88 |
Leafly | LFLY | Nov 21, 2024 | 1.51 | -4.43 |
Leap Therapeutics | LPTX | Nov 21, 2024 | 2.58 | -0.39 |
Lear | LEA | Nov 21, 2024 | 96.37 | +3.00 |
LeddarTech | LDTC | Nov 21, 2024 | 0.30 | +0.60 |
Lee Enterprises | LEE | Nov 21, 2024 | 16.10 | +0.06 |
Legacy Housing | LEGH | Nov 21, 2024 | 25.61 | +1.23 |
LegalZoom.com | LZ | Nov 21, 2024 | 7.76 | +1.70 |
Legato Merger III | LEGT | Nov 21, 2024 | 10.29 | +0.19 |
Legend Biotech ADR | LEGN | Nov 21, 2024 | 39.75 | -0.97 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Nov 21, 2024 | 40.61 | +1.22 |
Leggett & Platt | LEG | Nov 21, 2024 | 11.41 | +1.15 |
Leidos | LDOS | Nov 21, 2024 | 164.69 | +1.57 |
LeMaitre Vascular | LMAT | Nov 21, 2024 | 105.87 | +2.35 |
Lemonade | LMND | Nov 21, 2024 | 50.36 | +8.12 |
LendingClub | LC | Nov 21, 2024 | 15.90 | +5.23 |
LendingTree | TREE | Nov 21, 2024 | 43.65 | +1.54 |
Lendway | LDWY | Nov 21, 2024 | 3.85 | +6.35 |
Lennar A | LEN | Nov 21, 2024 | 168.07 | -0.10 |
Lennar B | LEN-B | Nov 21, 2024 | 159.17 | +0.20 |
Lennox International | LII | Nov 21, 2024 | 650.60 | +4.04 |
LENSAR | LNSR | Nov 21, 2024 | 7.45 | +2.34 |
LENZ Therapeutics | LENZ | Nov 21, 2024 | 34.32 | +1.21 |
Leonardo DRS | DRS | Nov 21, 2024 | 35.70 | +2.12 |
Lesaka Technologies | LSAK | Nov 21, 2024 | 5.30 | 0.00 |
Leslies | LESL | Nov 21, 2024 | 2.87 | +3.99 |
Levi Strauss & Co A | LEVI | Nov 21, 2024 | 15.97 | +1.08 |
Lexaria Bioscience | LEXX | Nov 21, 2024 | 2.16 | -1.82 |
Lexeo Therapeutics | LXEO | Nov 21, 2024 | 6.20 | +1.31 |
Lexicon Pharmaceuticals | LXRX | Nov 21, 2024 | 0.77 | -4.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.